Information for Authors Asian Pacif c Journal of Tropical Biomedicine

?

Information for Authors Asian Pacif c Journal of Tropical Biomedicine

GENERAL

Asian Pacif c Journal of Tropical Biomedicine is sponsored by Asian Pacif c Tropical Medicine Press and Hainan Medical Uni versity Journal Publisher , and aims to set up an acdemic communicating platform for Chinese and scientists all o ver the world on tropical biomedicine and related sciences.

The Journal invites concise reports of original research in all areas of tropical biomedicine and related f elds, both experimental and clinical, including modern, traditional and epidemiological studies, from any part of the w orld. Review articles based primarily on authors’ o wn research on internationally important topics will be accepted. Short communications and letters to the editor are also welcome. Authors are requested to submit a co vering letter indicating that their manuscript represents original unpublished material that has not been and will not be published elsewhere (if accepted). This restriction does not apply to results published as abstracts of communications, letters to the editor or as preliminary reports. By submitting a manuscript the authors w arrant that the y have obtained permission to use an y copyrighted or previously published materials.

Copyright

The submission of a manuscript by authors implies that the y automatically agree to assign exclusive copyright to the Asian Pacif c Journal of Tropical Biomedicine if the manuscript is accepted for publication. The work should not be published else where in an y form without the written permission of the Asian Pacif c Journal of Tropical Biomedicine. All rights of the articles published in the Asian Pacif c Journal of Tropical Biomedicine are reserv ed. No part of this publication may be reproduced, translated or transmitted in an y form or by an y means (electronic, mechanical or otherwise) without permission from the Asian Pacif c Journal of Tropical Biomedicine.

Conf ict of interest

All authors must disclose an y f nancial and personal relationships with other people or organizations that could inappropriately inf uence (bias) their w ork. Examples of potential conf icts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.

Ethics

Human e xperiments should be performed only in accordance with the ethical standards provided by the responsible committee of the institution and in accordance with the Declaration of Helsinki (as re vised in Edinburgh 2000), available at http://www.wma.net/e/policy/b3.htm. Animal experiments should be in accordance with the instructions for the care and use provided by the institution at which the research was carried out.

Informed consent

All investigations on human subjects must include a statement that the subject ga ve informed consent. Patient anonymity should be preserved. Photographs need to be cropped suff ciently to prevent human subjects being recognized (or an eye bar should be used).

MANUSCRIPT CONTENTS

Authors

All authors should ha ve participated suff ciently in the w ork to take public responsibility for the content. Written approval signed by all authors should be presented with the manuscript. The sequence of author’s names represent the de gree of contribution. Co-authorship should be indentif ed in the manuscript.

Manuscript

The manuscript should be submitted online through EVISE? online submission system or emails to the Editorial Off ce at: apjtbb@yahoo.com. Either method is applicable to submit manuscripts. Repeated submission is not necessary , and EVISE? online submission is recommended. The text should be double spaced and ha ve wide mar gins. The manuscript should be arranged in the follo wing order: 1) Title P age, 2) K eywords, 3) Abstract, 4) Corresponding author, 5) Introduction, 6) Materials and Methods, 7) Results, 8) Discussion, 9) Acknowledgments, 10) References, 11) Tables, 12) Figure Legends, and 13) Figures. Please indicate the page of your manuscripts to facilitate reviewing. Short communications not e xceeding two printed pages, including title, author aff liations, references, and one f gure or table, are acceptable for rapid publication if requested by the authors.

Letter to editor with criticisms or comments of less than 500 w ords and f ve references are welcome. Preference is given to letters related to articles published in the Asian Pacif c Journal of Tropical Biomedicine.

Title page

The title page should contain, on separate lines, the title of the manuscript, a running title of no more than 40 letters, the name(s) and aff liation(s) of the author(s), and the mailing address, telephone and fax numbers, and Email address of the corresponding author . The title must be informative, specif c, and concise. Serialization of articles into parts is not permitted; such

articles may be submitted independently with self-suff cient titles.

Keywords and Abstract

Provide 3-10 k ey words or phrases for inde xing purposes, using terms from the latest US National Library of Medicine’s Medical Subject Headings (MeSH) browser list at (http://www. nlm.nih.gov/mesh/meshhome.html). If appropriate MeSH terms are not available, other suitable terms may be used. Full-length submissions should include an abstract of up to 250 w ords in structured form, consisting of an Objective, Methods, Results, and Conclusion.

Text

The text should include the follo wing sections. The Introduction summarizes the rationale, provides a concise research background (not an exhaustive review) and states in one sentence the objective of the study. Do not include any results or the conclusions of the study. The Materials and Methods pro vide technical information about the study . Do not describe methodological details that ha ve been published pre viously. Specif cations (including the manuf acturer, city, and the country) should be gi ven for the main drugs, chemicals, and instruments. Indicate the statistical methods used and identify statistical signif cance using superscripts (a and b) following the data (aP ＜ 0.05,bP＜0.01). The Results are the f ndings, using SI units. In a sample, the number of effective digits is determined by the variation within the sample, that is, one-third of the standard deviation. Digits may be separated into groups of three by a small space. The Discussion deals with the interpretation of the results and their comparison with those of other studies. Do not repeat the results, do not review the literature, do not repeat textbook knowledge and do not cite references that do not have a close relationship with the present results. End with a brief conclusion linking back to the aim of the study.

Abbreviations

The use of abbre viations, except for units of measure, is discouraged. At the f rst appearance in the abstract and the text, abbreviations should be preceded by words for which they stand.

Tables

Tables must be concise and cited consecuti vely using Arabic numerals in the te xt (Table 1, Table 2, etc.). Each table should be typed on a separate sheet. The title of the table should clearly indicate the nature of the contents and suff cient details should be included in the footnote to facilitate interpretation without reference to the text. Use horizontal rules only.

Figures

Figures (photographs, drawings, diagrams and charts) should be clear , easily legible and cited consecutively using Arabic numerals in the text (Figure 1, Figure 2, etc.). Please supply f gures 1.5 to 2 times the size at which the y will be f nally reproduced. For line work, submit blackink drawings of professional quality. Micrographs or other glossy photographs must be of the highest quality. If a f gure comprises more than one glossy photograph, these should be marked A, B, C, etc. Figure legends should be marked clearly with the correspond letter. Legends should contain suff cient details to permit f gure interpretation without reference to the te xt. Scale markers should be indicated in the photographs. Color plates are also welcome. The choice of cover art illustration will be made by the Editor.

References

The Journal advocates the citation of new papers; old references are better replaced with updated ones. The authors are responsible for the correctness of references. References are numbered consecutively in the order in which the y appear in the te xt. Citation should be labelled in superscript parenthesis and should appear in front of the period or comma at the end of the sentence/clause. All references should be cited. Unpublished data, personal communications, abstracts at meetings and manuscripts submitted for publication are not acceptable as references. Information from such sources may be cited in the text with the sources gi ven in parentheses. References should be listed in numerical order in the Reference section. Journal titles should be abbre viated according to the list of Journals Indexed in Index Medicus or MEDLINE (www .nlm.nih.gov). Please note that no periods are used after the authors-initials or journal abbre viations. A period is used at the end of each reference. The type and punctuation of references is consistent with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals of the International Committee of Medical Journal Editors (http://www.ICMJE.org). Some examples are as follows:

Journal:

Journal article up to six authors (list all authors) Prasad TNVKV, Elumalai EK. Biofabrication of Ag nanoparticles using Moringa oleifera leaf extract and their antimicrobial activity. Asian Pac J Trop Biomed 2011; 1(6): 439-42.

Journal article more than six authors (list f rst six and add et al.)

Nam?duru ES, Tarak??o lu M, Nam?duru M, Kocaba R, Erba c? B, Meram I, et al. Increased serum nitric oxide and malondialdehyde levels in patients with acute intestinal amebiasis. Asian Pac J Trop Biomed 2011; 1(6): 478-81.

Book:

Waugh N, Ro yle P, Craigie I, Ho V, Pandit L, Ewings P , et al. Screening for cystic fi brosisrelated diabetes: a systematic review. Southampton (UK): NIHR Evaluation, Trials and Studies Coordinating Centre (UK); 2012, p. 15-8.

Chapter in a book:

Cubler DJ. Dengue/Dengue haemorrhagic fe ver: history and current status, in ne w treatment strategies for dengue and other f aviviral diseases. In: Bock G, Goode J, editors. Novartis foundation symposium 277. Chichester: John Wiley & Sons, Ltd; 2008.

Acknowledgments

Authors should obtain written permission for e veryone acknowledged by name, since readers may infer their endorsement of the paper and its conclusions.